Coming in 2019: an online program for JGH patients with scleroderma, a rare autoimmune disease characterized by hardening of connective tissues. Included are instructional videos and advice on developing a personalized exercise routine and setting realistic goals.
Nervous about possible risks during overnight surgery? Don’t be. A study conducted at the JGH concluded that patients who undergo emergency surgery during overnight hours are at no greater risk of mortality than those who are operated upon during the day.
Dental research is playing an increasingly significant role in the Lady Davis Institute, especially in an exploration of pain in and around the joint on either side of the jaw bone—second only to back disorders as a source of chronic pain.
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
A pioneering research program is connecting artificial intelligence with the new field of radiomics to heighten the effectiveness of cancer treatment by gleaning as much information as possible from radiological imaging technology.
The potential of manipulating a particular protein is being explored as a possible alternative to blood thinners, which are the standard of care for venous thromboembolism, but whose association with severe bleeding makes blood thinners an imperfect remedy.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
Dr. Pierre Pluye, a Senior Investigator in the Centre for Clinical Epidemiology and Community Studies at the Lady Davis Institute, has been named 2017 Family Medicine Researcher of the Year by the College of Family Physicians of Canada.